Literature DB >> 8035200

Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor.

L F Lin1, T J Zhang, F Collins, L G Armes.   

Abstract

The rat glial cell line B49 releases into its culture medium a potent neurotrophic factor that exhibits relative specificity for the dopaminergic neurons in dissociated cultures of rat embryonic midbrain. This factor is a heparin-binding, basic protein that is heterogeneously glycosylated and migrates on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and on molecular sieve chromatography with an apparent mass of approximately 33-45 kDa. The factor behaves like a disulfide-bonded homodimer, whose biological activity is destroyed by reduction of disulfide bonds but not by SDS-PAGE or reversed-phase (RP)-HPLC. The apparent mass of the monomer is approximately 16 kDa after deglycosylation with N-Glycanase. This factor has been purified 34,000-fold to apparent homogeneity by a combination of heparin-affinity chromatography, molecular sieving chromatography, SDS-PAGE, and RP-HPLC. The purified rat protein promotes the survival, morphological differentiation, and high-affinity dopamine reuptake of dopaminergic neurons in midbrain cultures, without obvious effects on total neurons or glia and without increasing high-affinity GABA or serotonin reuptake. The purified protein exhibits an EC50 in midbrain cultures at approximately 40 pg/ml, or 1 pM, and has unique amino-terminal and internal amino acid sequences. The sequences provide a basis for cloning and expression of the gene for rat and human glial cell line-derived neurotrophic factor (GDNF), confirming that the protein purified as reported here is GDNF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035200     DOI: 10.1046/j.1471-4159.1994.63020758.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

2.  Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.

Authors:  Kiren Ubhi; Edward Rockenstein; Michael Mante; Chandra Inglis; Anthony Adame; Christina Patrick; Kristen Whitney; Eliezer Masliah
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Incorporation of heparin into biomaterials.

Authors:  Shelly E Sakiyama-Elbert
Journal:  Acta Biomater       Date:  2013-09-08       Impact factor: 8.947

Review 4.  Gene therapy for Parkinson's disease.

Authors:  P Horellou; J Mallet
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

5.  Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

Authors:  A Bilang-Bleuel; F Revah; P Colin; I Locquet; J J Robert; J Mallet; P Horellou
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

6.  Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers.

Authors:  Ahmet Höke; Tony Ho; Thomas O Crawford; Carl LeBel; Dana Hilt; John W Griffin
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways.

Authors:  Jing-Jun Sun; Ying Liu; Zhu-Rong Ye
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

8.  Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis.

Authors:  Q C Vega; C A Worby; M S Lechner; J E Dixon; G R Dressler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Short-term exercise increases GDNF protein levels in the spinal cord of young and old rats.

Authors:  M J McCullough; A M Gyorkos; J M Spitsbergen
Journal:  Neuroscience       Date:  2013-03-14       Impact factor: 3.590

10.  Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's Disease.

Authors:  Amirah E-E Aly; Brendan T Harmon; Linas Padegimas; Ozge Sesenoglu-Laird; Mark J Cooper; Barbara L Waszczak
Journal:  Mol Neurobiol       Date:  2018-05-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.